Skip to main
PATH

UiPath (PATH) Stock Forecast & Price Target

UiPath (PATH) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 0%
Hold 80%
Sell 7%
Strong Sell 0%

Bulls say

UiPath is well-positioned to capture market share in the rapidly growing and evolving space of automation. With a comprehensive platform that offers a range of automation technologies, including RPA, API, and AI, UiPath is well-equipped to tackle a broad range of repetitive tasks across industries. Additionally, the company's focus on expanding into key verticals and offering outcome-oriented solutions adds to its growth potential. Furthermore, strong financial performance, including consistent growth in Annualized Renewal Run-rate (ARR) and revenue, coupled with improved operational efficiency and profitability, paints a positive outlook for UiPath's stock.

Bears say

UiPath is experiencing steady growth and has the potential for re-acceleration, but sustainability and execution remain key concerns, as the company faces headwinds in the competitive RPA market and management transitions. While ARR and NNARR have shown improvement in Q2/27, the company needs to show consistent growth and address investor concerns through their upcoming investor day. Their focus on AI and innovative products may help differentiate them, but for now, the market is adequately pricing in this potential.

UiPath (PATH) has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UiPath (PATH) Forecast

Analysts have given UiPath (PATH) a Hold based on their latest research and market trends.

According to 15 analysts, UiPath (PATH) has a Hold consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UiPath (PATH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.